alzAPOE therapeutics change feed
Snapshot

Metabolic dysfunction and impaired brain insulin signalling contribute to Alzheimer's; GLP-1 receptor agonism is protective

1 tracked therapeutic, 2 registered studies.

1 source is not reporting cleanly — changes may be missingeuropepmc STALE

Changes that would have come from the sources below are absent from this feed. Absence here means “not observed”, not “did not happen”.

  • Europe PMC (europepmc, daily) — last successful fetch (2 days ago), last run status ok — past its staleness threshold.

Maturity

  1. ObservationA phenomenon has been noted.
  2. Target validationA causal role has been tested in models.
  3. Tool compoundA molecule engages the target but is not developable.
  4. Development candidateA specific therapeutic is in preclinical development.
  5. ClinicalAt least one therapeutic is in human trials.

Clinical — At least one therapeutic is in human trials. This value is set by a curator and is not derived from the therapeutics below: a thesis with no therapeutics still has a maturity, and that is the case this entity exists to express. The furthest any therapeutic here has reached is phase 3.

Therapeutics pursuing this thesis — 1

TherapeuticSponsorModalityStatusTrialsPubsLast change
semaglutide (oral)Novo Nordisk A/SpeptidePhase 320none observed

Evidence — 0

No publication is linked to this thesis yet. Papers attach to a thesis only when a human approves the link — the same rule that governs therapeutic-level citations. An unlinked literature is an unworked queue, not an absent one.

Curator notes — written by a human, not derived

Contextual rather than mechanistic: no established APOE mechanism. Tracked because two Phase 3 readouts of this size reshape what the field believes is treatable, whatever they show, and because APOE-stratified subgroup analyses from trials this large would be directly in scope. Liraglutide (Imperial) and exenatide (NIA, terminated) pursue the same thesis and are not yet tracked as separate assets.

Change history across this thesis — 0

No changes detected for any therapeutic pursuing this thesis as of the snapshot taken .

This is not the same as nothing having happened. The oldest source in this snapshot last succeeded (2 days ago), and registry and filing data lag the events they describe. See methodology.

Last reviewed by a curator (today). A thesis nobody has re-examined is an opinion presented as a position.